Jeffrey Ryan Stewart Insider Trading $ABBV AbbVie Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey Ryan Stewart.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Ryan Stewart. Jeffrey Ryan Stewart is EVP, Commercial Operations in AbbVie Inc. ($ABBV) and SVP, US Commercial Operations in AbbVie Inc. ($ABBV).
Jeffrey Ryan Stewart in AbbVie Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Ryan Stewart: EVP, Commercial Operations, SVP, US Commercial Operations
Holdings: 64,742 shares
Current Value: $3,926,602
Latest Transaction: Mar 02 2021
$ABBV Market Capitalization: $98.42B
$ABBV Previous Close: $60.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jeffrey Ryan Stewart in AbbVie Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Sell | S | 108.59 | 13,773 | 1,495,576 | 50,969 | 64.7 K to 51 K (-21.27 %) |
| Mar 02 2021 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 107.74 | 10,957 | 1,180,507 | 64,742 | 75.7 K to 64.7 K (-14.47 %) |
| Dec 31 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | EVP, Commercial Ope ... | Option Exercise | M | 51.42 | 25,290 | 1,300,412 | 0 | |
| Dec 31 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | EVP, Commercial Ope ... | Sell | S | 105.00 | 25,290 | 2,655,450 | 50,969 | 76.3 K to 51 K (-33.16 %) |
| Dec 31 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | EVP, Commercial Ope ... | Buy | M | 51.42 | 25,290 | 1,300,412 | 76,259 | 51 K to 76.3 K (+49.62 %) |
| Dec 11 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 108.67 | 1,791 | 194,628 | 50,969 | 52.8 K to 51 K (-3.39 %) |
| May 12 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Sell | S | 90.00 | 23,024 | 2,072,211 | 52,760 | 75.8 K to 52.8 K (-30.38 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 85.42 | 9,703 | 828,830 | 75,784 | 85.5 K to 75.8 K (-11.35 %) |
| Dec 12 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 86.44 | 1,713 | 148,072 | 63,591 | 65.3 K to 63.6 K (-2.62 %) |
| Aug 20 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Buy | P | 64.44 | 15,552 | 1,002,169 | 65,304 | 49.8 K to 65.3 K (+31.26 %) |
| Mar 04 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Payment of Exercise | F | 79.41 | 6,907 | 548,485 | 49,752 | 56.7 K to 49.8 K (-12.19 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Option Exercise | A | 79.02 | 25,700 | 2,030,814 | 25,700 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 2,970 | 0 | 56,659 | 53.7 K to 56.7 K (+5.53 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 3,909 | 0 | 53,689 | 49.8 K to 53.7 K (+7.85 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 3,645 | 0 | 49,780 | 46.1 K to 49.8 K (+7.90 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 5,062 | 0 | 46,135 | 41.1 K to 46.1 K (+12.32 %) |
| Dec 12 2018 | ABBV | AbbVie Inc. | Stewart Jeffrey Ryan | SVP, US Commercial ... | Grant | A | 0.00 | 11,595 | 0 | 41,073 | 29.5 K to 41.1 K (+39.33 %) |
Page: 1